Author: Gail M. Wilkes
Edition: 1st
Publisher: Jones & Bartlett Pub
Binding: Paperback
ISBN: 0763739235
2006 Oncology Nursing Drug Handbook
2006 Oncology Nursing Drug Handbook is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs. Medical books 2006 Oncology Nursing Drug Handbook. This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Updated annually, the 2006 edition includes the following new drugs: four antineoplastic agents (clofarabine, histrelin implant, paclitaxel protein bound particles for injection, TLK 286), four antimicrobial agents (micafungin, rifaximin, gemifloxacin, tigecycline), two immunotherapy/biotherapy symptom management agents (Imiquimod 5% cream., palifermin), and eight molecularly targeted drugs (lapatanib, panitumumab, pertuzumab, sorafeni (BAY 43-9006), sunitinib malate (sutent, SU11246), temsirolimus, tipifarnib, vatalanib), and one symptom management drug (ziconotide intrathecal infusion) Medical books 2006 Oncology Nursing Drug Handbook , 9780763739232. 2006 Oncology Nursing Drug Handbook , ISBN-13: 9780763739232, ISBN-10: 0763739235
Download link for 2006 Oncology Nursing Drug Handbook Gail M. Wilkes/ Margaret Barton-burke
2006 Oncology Nursing Drug Handbook , ISBN-13: 9780763739232, ISBN-10: 0763739235
New Paperback.
Jones & Bartlett Pub 2005-12-22. Paperback. Used - Very Good. Very good condition.
Medical Book 2006 Oncology Nursing Drug Handbook
This text reviews drug information from the nurse's point of view, and helps the nurse focus on minimizing toxicity. This essential reference provides valuable information on effective symptom management and chemotherapy administration for the oncology nurse. Updated annually, the 2006 edition includes the following new drugs: four antineoplastic agents (clofarabine, histrelin implant, paclitaxel protein bound particles for injection, TLK 286), four antimicrobial agents (micafungin, rifaximin, gemifloxacin, tigecycline), two immunotherapy/biotherapy symptom management agents (Imiquimod 5% cream., palifermin), and eight molecularly targeted drugs (lapatanib, panitumumab, pertuzumab, sorafeni (BAY 43-9006), sunitinib malate (sutent, SU11246), temsirolimus, tipifarnib, vatalanib), and one symptom management drug (ziconotide intrathecal infusion). In addition, indications and additional toxicity data have been updated for individual drugs, such as bevacizumab, cetuximab, and gefitinib.
